The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).
 
Patrick Joseph Grohar
Stock and Other Ownership Interests - AI Therapeutics
Honoraria - Vertex
Consulting or Advisory Role - InhibRx; Jazz Pharmaceuticals; OrphAI Therapeutics
Research Funding - InhibRx; Janssen Oncology; Jazz/SU2C
Patents, Royalties, Other Intellectual Property - We have a patent pending for mithramycin and analogs as targeted agents for SWI/SNF mutant tumors. It has not issued and is not currently licensed.
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Mylan; Sanofi
 
Rachel Heise
Employment - CSL Behring (I)
 
Leo Mascarenhas
Consulting or Advisory Role - Gilead Sciences; Novartis
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bayer (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Children's Oncology Group Foundation; The Pablove Foundation
 
John Glod
Research Funding - AdaptImmune; Apollomics (Inst); GlaxoSmithKline/Adaptimmune (Inst)
 
Mary Frances Frances Wedekind
No Relationships to Disclose
 
Jenna Marie Gedminas
No Relationships to Disclose
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Robert G. Maki
Consulting or Advisory Role - Boehringer Ingelheim; Deciphera; Eisai; GlaxoSmithKline; Medtronic; PEEL Therapeutics
Speakers' Bureau - MJH Life Sciences
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); InhibRx (Inst); Regeneron (Inst); SARC: Sarcoma Alliance for Research though Collaboration (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Stand up to Cancer
(OPTIONAL) Uncompensated Relationships - Fondazione Enrico Pallazzo
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Generate Biomedicines (I)
Leadership - New Age Industries (I)
Stock and Other Ownership Interests - Acceleron Pharma (I)
Consulting or Advisory Role - Animal Cancer Foundation; AstraZeneca; PetDx
Research Funding - Gradalis
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb/Celgene
 
Theodore Willis Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Honoraria - Cook Children's Hospital
Consulting or Advisory Role - AI Therapeutics; Aptitude Health; Bayer; GentiBio; ITM Oncologics; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Medscape; Menarini; Novartis; Pyramid Biosciences; Targeted Oncology; Treeline Biosciences
Research Funding - Advanced Accelerator Applications/Novartis; Bayer (Inst); BioAtla; Bristol-Myers Squibb; Lilly; Pfizer (Inst); Roche; Roche/Genentech; Taiho Oncology; Turning Point Therapeutics (Inst)
 
Mark Diamond
No Relationships to Disclose
 
Fariba Navid
Research Funding - Bayer (Inst)
 
Ryan David Roberts
Consulting or Advisory Role - AstraZeneca; Dompé Farmaceutici
Patents, Royalties, Other Intellectual Property - Il-8 inhibitors for use in the treatment of some sarcomas
 
Brigitte C. Widemann
No Relationships to Disclose
 
Denise K. Reinke
No Relationships to Disclose
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; InhibRx; Jazz Pharmaceuticals; SpringWorks Therapeutics
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Cogent Biosciences (Inst); Cornerstone Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Janssen (Inst); Kronos Bio (Inst); Pfizer (Inst); PTC Therapeutics (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer